Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease.
Schölmerich J, Fellermann K, Seibold FW, Rogler G, Langhorst J, Howaldt S, Novacek G, Petersen AM, Bachmann O, Matthes H, Hesselbarth N, Teich N, Wehkamp J, Klaus J, Ott C, Dilger K, Greinwald R, Mueller R; International TRUST-2 Study Group. Schölmerich J, et al. Among authors: wehkamp j. J Crohns Colitis. 2017 Apr 1;11(4):390-399. doi: 10.1093/ecco-jcc/jjw184. J Crohns Colitis. 2017. PMID: 27707789 Free PMC article. Clinical Trial.
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease.
Leinwand KL, Jones AA, Huang RH, Jedlicka P, Kao DJ, de Zoeten EF, Ghosh S, Moaddel R, Wehkamp J, Ostaff MJ, Bader J, Aherne CM, Collins CB. Leinwand KL, et al. Among authors: wehkamp j. J Crohns Colitis. 2017 Oct 27;11(11):1369-1380. doi: 10.1093/ecco-jcc/jjx096. J Crohns Colitis. 2017. PMID: 28981653 Free PMC article.
Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.
Gersemann M, Becker S, Nuding S, Antoni L, Ott G, Fritz P, Oue N, Yasui W, Wehkamp J, Stange EF. Gersemann M, et al. Among authors: wehkamp j. J Crohns Colitis. 2012 May;6(4):425-34. doi: 10.1016/j.crohns.2011.09.013. Epub 2011 Nov 15. J Crohns Colitis. 2012. PMID: 22398066
Paneth's disease.
Wehkamp J, Stange EF. Wehkamp J, et al. J Crohns Colitis. 2010 Nov;4(5):523-31. doi: 10.1016/j.crohns.2010.05.010. Epub 2010 Jul 6. J Crohns Colitis. 2010. PMID: 21122555
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP; Secukinumab in Crohn's Disease Study Group. Hueber W, et al. Among authors: wehkamp j. Gut. 2012 Dec;61(12):1693-700. doi: 10.1136/gutjnl-2011-301668. Epub 2012 May 17. Gut. 2012. PMID: 22595313 Free PMC article. Clinical Trial.
Intestinal barrier in inflammatory bowel disease.
Antoni L, Nuding S, Wehkamp J, Stange EF. Antoni L, et al. Among authors: wehkamp j. World J Gastroenterol. 2014 Feb 7;20(5):1165-79. doi: 10.3748/wjg.v20.i5.1165. World J Gastroenterol. 2014. PMID: 24574793 Free PMC article. Review.
138 results